Skip to main content
Clinical Trials/NCT03628703
NCT03628703
Completed
N/A

Using Repetitive Transcranial Magnetic Stimulation to Modulate Response Inhibition in Tourette Syndrome

Children's Hospital Medical Center, Cincinnati1 site in 1 country10 target enrollmentApril 22, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Tourette Syndrome
Sponsor
Children's Hospital Medical Center, Cincinnati
Enrollment
10
Locations
1
Primary Endpoint
Stop Signal Reaction Time (SSRT)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Tics are the hallmark symptoms in Tourette Syndrome. Patients with Tourette Syndrome have difficulties controlling unwanted movements. The ability to control the motor system involves the pre-supplementary motor area (pre-SMA) in the brain. In this study, we will use Transcranial Magnetic Stimulation to modulate the pre-SMA and determine effect on the ability to stop an unwanted action in a behavior task (stop signal task).

Registry
clinicaltrials.gov
Start Date
April 22, 2019
End Date
March 15, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Tourette Syndrome

Exclusion Criteria

  • Autism spectrum disorder
  • Mood disorder
  • Implanted medical device (e.g. pacemaker, shunt, pumps)

Outcomes

Primary Outcomes

Stop Signal Reaction Time (SSRT)

Time Frame: 30 minutes after Repetitive Transcranial Magnetic Stimulation (as it takes about 30 minutes to complete the modified Slater-Hammel stop signal task)

SSRT measured from modified Slater-Hammel stop signal task performance. The SSRT is calculated by subtracting the average stop signal delay (msec) from the average go-trial reaction time. The SSRT is a measure of inhibitory behavior. The lower the SSRT value means a person is better at inhibitory control. The higher the SSRT value means a person is worse at inhibitory control.

Study Sites (1)

Loading locations...

Similar Trials